Add BrightSurf on Google Email

Johns Hopkins Medicine


How hypoxia helps cancer spread

Scientists at Johns Hopkins Medicine identified 16 genes that breast cancer cells use to survive in the bloodstream, including MUC1, which is already in clinical trials. The research showed that hypoxic cells are able to migrate to higher oxygen levels and form metastasis in the body, leading to a worse prognosis.

SourceJohns Hopkins Medicine·JournalNature Communications·DateNov 5, 2024

Scientists determine why some patients don’t respond well to wet macular degeneration treatment, show how new experimental drug can bridge gap

Researchers have identified a new experimental drug that can bridge the gap between patients with wet age-related macular degeneration (AMD) and existing treatments. The drug, 32-134D, decreases levels of a key protein involved in AMD, leading to improved vision outcomes.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateNov 4, 2024

Study suggests a healthy diet may help keep low grade prostate cancer from progressing to more dangerous states during active surveillance

A new study suggests that a healthy diet may help keep low-grade prostate cancer from progressing to more aggressive states in men undergoing active surveillance. The research team led by Johns Hopkins Medicine found that a reduced risk of prostate cancer progression is associated with a healthy diet.

SourceJohns Hopkins Medicine·JournalJAMA Oncology·DateOct 17, 2024

Low gravity in space travel found to weaken and disrupt normal rhythm in heart muscle cells

Researchers found that low gravity conditions in space weaken and disrupt the normal rhythmic beats of human bioengineered heart tissue samples. The tissues on the International Space Station beat about half as strong as those on Earth, and developed irregular beating patterns that can cause a human heart to fail.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateSep 23, 2024

Super-chilled brain cell molecules reveal how epilepsy drug works

Scientists at Johns Hopkins Medicine have discovered the mechanism of action of the widely-used epilepsy drug perampanel, which targets the AMPA receptor to dampen brain cell excitability. The study provides new insights into the potential applications of perampanel in treating other neurological conditions such as Alzheimer’s disease,...

SourceJohns Hopkins Medicine·JournalNature Structural & Molecular Biology·DateJun 10, 2024

Johns Hopkins Children’s Center study shows more than just social media use may be causing depression in young adults

A Johns Hopkins Children's Center study found that social media use is associated with depression in young adults, but may not be the sole cause. Participants who were more depressed also tended to spend more time on social media, while excessive screen time was linked to lower green space exposure and cannabis use.

SourceJohns Hopkins Medicine·JournalInternational Journal of Mental Health and Addiction·DateMay 29, 2024

Drug helps reprogram macrophage immune cells, suppress prostate and bladder tumor growth

A novel therapy has been developed to reprogram macrophage immune cells, shifting their balance toward antitumor activity. The treatment, JHU083, blocks the use of glutamine in tumors, reducing growth and triggering cell death. It also boosts immune-activating macrophages, recruiting tumor-killing T-cells and natural killer cells.

SourceJohns Hopkins Medicine·JournalCancer Immunology Research·DateMay 21, 2024

Study suggests high-frequency electrical ‘noise’ results in congenital night blindness

Researchers at Johns Hopkins Medicine used genetically engineered mice to study the mechanism of congenital stationary night blindness. The findings demonstrate that a mutation in the rhodopsin gene produces unusual background electrical activity, desensitizing rods and causing poor vision in low-light settings.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateMay 16, 2024

Variations in telomere lengthening genes may predispose some people to papillary thyroid cancer

Researchers found a correlation between genetic variations in three telomere-related genes and an increased risk of developing papillary thyroid cancer. The study suggests that individuals with these variants may benefit from closer monitoring for secondary cancers, and highlights the role of long telomeres in cancer development.

SourceJohns Hopkins Medicine·JournalAmerican Journal of Human Genetics·DateMay 13, 2024